Marc P. Bonaca, MD, MPH

home / authors / marc-bonaca-md-mph

Articles

Video: Exploring Bempedoic Acid: Clinical Indications, Efficacy, and Future Directions in Cardiovascular Risk Management

Pam R. Taub, MD, FACC, FASPC ;Marc P. Bonaca, MD, MPH

December 17th 2024

Panelists discuss how bempedoic acid offers a promising alternative for patients who are statin-intolerant, demonstrating efficacy in reducing major cardiovascular events and low-density lipoprotein cholesterol, while addressing its role in managing residual cardiovascular risk, particularly in high-risk populations.

Exploring Bempedoic Acid: Clinical Indications, Efficacy, and Future Directions in Cardiovascular Risk Management

Pam R. Taub, MD, FACC, FASPC ;Marc P. Bonaca, MD, MPH

December 13th 2024

Concluding Thoughts

Deepak Bhatt, MD, MPH;Marc P. Bonaca, MD, MPH;Sahil Parikh, MD;Eric Secemsky, MD;Amy Pollak, MD;Manesh Patel, MD

June 10th 2022

A panel of expert cardiologists share their concluding thoughts on management of polyvascular disease in clinical practice.

Unmet Needs and Emerging Approaches to Management of Polyvascular Disease

Deepak Bhatt, MD, MPH;Marc P. Bonaca, MD, MPH;Sahil Parikh, MD;Eric Secemsky, MD;Amy Pollak, MD;Manesh Patel, MD

June 10th 2022

Cardiologists share unmet needs and emerging approaches to management of patients with polyvascular disease.

VOYAGER Trial and DPI in Clinical Practice

Deepak Bhatt, MD, MPH;Marc P. Bonaca, MD, MPH;Sahil Parikh, MD;Eric Secemsky, MD;Amy Pollak, MD;Manesh Patel, MD

June 10th 2022

Manesh Patel, MD, reviews VOYAGER trial data and expert cardiologists share where they use DPI [dual pathway inhibition] in their practices.

COMPASS Trial for CAD and PAD

Deepak Bhatt, MD, MPH;Marc P. Bonaca, MD, MPH;Sahil Parikh, MD;Eric Secemsky, MD;Amy Pollak, MD;Manesh Patel, MD

June 3rd 2022

Expert cardiologists discuss data from COMPASS trial and the role of rivaroxaban and low-dose aspirin in treatment of patients with CAD and PAD.

Access to and Awareness of DPI for Polyvascular Disease

Deepak Bhatt, MD, MPH;Marc P. Bonaca, MD, MPH;Sahil Parikh, MD;Eric Secemsky, MD;Amy Pollak, MD;Manesh Patel, MD

June 3rd 2022

Sahil Parikh, MD, shares how lack of access to or awareness of DPI [dual pathway inhibition] causes many practices and health care providers to face a challenge in treating CAD [coronary artery disease].

Direct Oral Anticoagulants and Dosing

Deepak Bhatt, MD, MPH;Marc P. Bonaca, MD, MPH;Sahil Parikh, MD;Eric Secemsky, MD;Amy Pollak, MD;Manesh Patel, MD

May 27th 2022

Drs Patel and Bhatt discuss importance of correct dosing of direct oral anticoagulants in treatment of cardiovascular diseases.

Dual Pathway Inhibition in Coronary Artery Disease

Deepak Bhatt, MD, MPH;Marc P. Bonaca, MD, MPH;Sahil Parikh, MD;Eric Secemsky, MD;Amy Pollak, MD;Manesh Patel, MD

May 27th 2022

Expert cardiologists provide an overview of dual pathway inhibition, modulation of thrombotic risk and treatment of CAD.

Risk-Benefit Analysis in Treatment Selection in CAD

Deepak Bhatt, MD, MPH;Marc P. Bonaca, MD, MPH;Sahil Parikh, MD;Eric Secemsky, MD;Amy Pollak, MD;Manesh Patel, MD

May 20th 2022

Dr Amy Pollak shares her thoughts on risk-benefit analysis when evaluating patients with high thrombotic/bleeding risk and treatment selection.

Stents in Treatment of CAD and PAD

Deepak Bhatt, MD, MPH;Marc P. Bonaca, MD, MPH;Sahil Parikh, MD;Eric Secemsky, MD;Amy Pollak, MD;Manesh Patel, MD

May 20th 2022

Dr Eric Secemsky discusses how use of stents has evolved over the years in treatment of polyvascular disease.

Dual Antiplatelet Therapy in CAD

Deepak Bhatt, MD, MPH;Marc P. Bonaca, MD, MPH;Sahil Parikh, MD;Eric Secemsky, MD;Amy Pollak, MD;Manesh Patel, MD

May 13th 2022

Dr Manesh Patel and other experts discuss the role of dual antiplatelet therapy (DAPT) in treatment of coronary artery disease.

Regimen Intensification in Polyvascular Disease

Deepak Bhatt, MD, MPH;Marc P. Bonaca, MD, MPH;Sahil Parikh, MD;Eric Secemsky, MD;Amy Pollak, MD;Manesh Patel, MD

May 13th 2022

Drs Marc Bonaca and Deepak Bhatt discuss the role of therapy intensification when managing high-risk patients with polyvascular disease.

Guidelines and Management of Patients With Polyvascular Disease

Deepak Bhatt, MD, MPH;Marc P. Bonaca, MD, MPH;Sahil Parikh, MD;Eric Secemsky, MD;Amy Pollak, MD;Manesh Patel, MD

May 6th 2022

Expert cardiologists discuss CAD guidelines and approaches to management of patients with polyvascular disease.

Provider Engagement and Screening

Deepak Bhatt, MD, MPH;Marc P. Bonaca, MD, MPH;Sahil Parikh, MD;Eric Secemsky, MD;Amy Pollak, MD;Manesh Patel, MD

May 6th 2022

Dr Sahil Parikh and other experts discuss engagement of cardiologists in patients diagnosed with polyvascular disease and challenges in screening patients.

Screening for Polyvascular Disease

Deepak Bhatt, MD, MPH;Marc P. Bonaca, MD, MPH;Sahil Parikh, MD;Eric Secemsky, MD;Amy Pollak, MD;Manesh Patel, MD

April 29th 2022

Dr Amy Pollak and other experts discuss their recommendations for screening for CAD and PAD in asymptomatic patients.

Overview of Polyvascular Disease and Coronary Artery Disease

Deepak Bhatt, MD, MPH;Marc P. Bonaca, MD, MPH;Sahil Parikh, MD;Eric Secemsky, MD;Amy Pollak, MD;Manesh Patel, MD

April 29th 2022

Drs Marc Bonaca and Manesh Patel provide an overview of Polyvascular Disease and prevalence of coronary artery disease and peripheral artery disease.